XML 11 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Equity (Deficit) - USD ($)
Common shares
Contributed surplus
Deficit
Non-controlling interest
Total
Balance, beginning of period at Dec. 31, 2018 $ 26,882,622 $ 1,745,079 $ (14,531,401) $ 544,465 $ 14,640,765
Balance, beginning of period (shares) at Dec. 31, 2018 47,524,375        
Net comprehensive loss for the year     (15,909,879) 57,590 (15,852,289)
Issuance of common shares - financing (note 13) $ 20,604,207 355,660     20,959,867
Issuance of common shares - financing (shares) 9,409,000        
Issuance of common shares - acquisition (note 5, note 13) $ 2,611,044       2,611,044
Issuance of common shares - acquisition (shares) 1,431,736        
Exercise of stock options (note 13) $ 87,883 (33,717)     54,166
Exercise of stock options (shares) 53,332        
Share-based compensation (note 14)   690,230     690,230
Distributions to non-controlling interest       (562,650) (562,650)
Non-controlling interest subsidiary investment (note 22)       405,000 405,000
Balance, end of period at Dec. 31, 2019 $ 50,185,756 2,757,252 (30,441,280) 444,405 22,946,133
Balance, end of period (shares) at Dec. 31, 2019 58,418,443        
Net comprehensive loss for the year     (29,663,540) (739,181) (30,402,721)
Issuance of common shares - financing (note 13) $ 9,943,886       9,943,886
Issuance of common shares - financing (shares) 9,093,940        
Share-based compensation (note 14)   591,384     591,384
Distributions to non-controlling interest       (143,500) (143,500)
Acquisition of subsidiary non-controlling interest (note 22)     (97,156) 45,716 (51,440)
Balance, end of period at Dec. 31, 2020 $ 60,129,642 $ 3,348,636 $ (60,201,976) $ (392,560) $ 2,883,742
Balance, end of period (shares) at Dec. 31, 2020 67,512,383